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Abstract We describe the case of a 53-year-old man who
underwent a left metal-on-metal hip resurfacing in 2015.
Component size mismatch (CSM) was suspected because of
the patient’s immediate post-operative mechanical symptoms
and high metal ion levels. Surgical notes indicated the appro-
priate combinations of implants were used. However, we de-
tected a mismatch using computed tomography. Revision was
performed and subsequent measurements of explanted com-
ponents confirmed the mismatch. To our knowledge, this case
is the first report of a CTmethod being used in a patient to pre-
operatively identify CSM.
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Introduction
Size mismatch of components used in total hip arthroplasty, is
a Bserious, largely preventable^ incident that has devastating
effects for patients [1]. The risk of component size mismatch
(CSM) is predicted to rise, owing to growing numbers of
increasingly complex components being used in orthopaedics
[2]. The National Joint Registry for England, Wales and
Northern Ireland reported that 62 out of the 9,676 revisions
performed in 2013 were due to CSM of the head–acetabular
socket (0.64 %) [3]. However, it is likely that CSM is under-
estimated (with an incidence closer to 1 %), because of diffi-
culties in intra-operative and plain radiograph detection [2].
The detection of metal-on-metal (MoM) CSM using plain
radiographs remains challenging (Figs. 1, 2). In a recent sur-
vey, the mean detection rate, by surgeons using plain radio-
graphs, of MoM CSM was 27.7 % (see Appendix) [2]. The
low contrast between the cup and head component in MoM
hip replacements, combined with the low intended clearance
of bearing surfaces (approximately 200 μm) explains the dif-
ficulty in radiograph detection. In contrast, detection of metal-
on-polyethylene CSM is possible using plain radiographs, and
has been reported previously [4, 5].
To our knowledge, this case is the first report of CT being
used in a patient to pre-operatively identify CSM. This man-
uscript does not address the medico-legal implications of this
issue.
Case report
In 2015, a 53-year-old man (with previous right hip
resurfacing) underwent a MoM hip resurfacing for left
hip osteoarthritis. Intra-operatively, the consultant ortho-
paedic surgeon (who has 17 years’ experience performing
total hip resurfacing) suspected that the head was under-
sized compared with the acetabular cup. The component’s
engravings could not be visualised intra-operatively. The
implant manufacturer was informed via the representative,
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but reported that the size of the components would be as
marked on the boxes. Hence, the components were left in
situ. The acetabular cup’s outer diameter was recorded
(using the manufacturer’s labels) as 56 mm, the acetabular
bearing surface diameter was 48 mm and the femoral head
component’s diameter was recorded as 48 mm.
Anterior–posterior and lateral X-rays of the patient’s hip
were acquired (Figs. 1, 2). No obvious abnormalities were
seen on the radiographs and the patient was subsequently
discharged with an early 2-week review, because of the sur-
geon’s initial intra-operative suspicion of CSM. At 2 weeks
the patient’s incision had healed and the patient reported me-
chanical symptoms of instability and Bsquelching^ of the
component. This was very dissimilar to the immediate post-
operative symptoms of the previous contralateral hip
resurfacing.
Blood cobalt and chromium levels were measured at
5 weeks post-operatively. Five-week metal ion results were
significantly elevated: cobalt was 69.3 ppb and chromium
was 54.8 ppb. This, combined with the patient’s mechanical
post-operative symptoms, apparently normal AP and lateral
radiographs and the initial suspicion of CSM, prompted fur-
ther imaging.
Consequently, a low-dose CT scan (1.4 mSv) of the
patient’s hip was obtained (Fig. 3). The low-dose CT scan
was obtained using a SOMATOM Definition AS 128-slice
CT scanner (Siemens Heathineers, Erlangen, Germany)
using the CT protocol shown in Table 1. Three-
dimensional models of the components were produced.
The centre of rotation of each component was compared
(Fig. 4) and the distance between the edge of the acetab-
ular cup and femoral head surface was measured (Fig. 5).
This method works on the premise that a fully engaged
head should be equally spaced from the outer surface of
the acetabular cup and that the centre of rotation of
spheres fitted to the outer surface of the acetabular and
femoral head components should overlap, provided that
an offset-bore acetabular component has not been used.
Three-dimensional analyses of the CT scan indicated a po-
tential CSM (Figs. 4, 5). Results suggested that the acetabular-
bearing diameter was 50 mm, highly suggestive of a 2-mm
CSM, with the acetabular bearing surface 2 mm greater than
the femoral head. Revision was recommended on this basis.
The company was informed throughout the post-operative
follow-up via the local representative. Based on the informa-
tion that the company had seen they advised against revision
surgery and suggested that close clinical follow-up of the pa-
tient might be arranged.
The resurfacing was revised 10 weeks post-primary
surgery, with the Adept hip resurfacing (MatOrtho,
Surrey, UK) exchanged for a Trinity Metafix (Corin,
Cirencester, UK). The explanted Adept hip resurfacing
components, both acetabular and femoral components,
were sent to the London Implant Retrieval Centre for
analysis. On visual inspection, implant labelling pointed
to a bearing size mismatch (Fig. 6). These measurements
were confirmed using a coordinate measuring machine
(internal diameter of the cup = 49.98 mm, outer diameter
of the head = 47.84 mm). Wear analysis of both compo-
nents was also performed. The volume of wear in the
acetabular component was 20.59 mm3. This gives a pre-
dicted 1-year wear of 107 mm3. The volume of wear of
the femoral head component was 10.14 mm3. This gives a
predicted 1-year wear of 47.84 mm3. Under standard
walking conditions, with correctly positioned compo-
nents, assuming 1.9 million cycles per annum [6], the
expected wear rate should be less than 2 mm3/year [7].
Fig. 2 Post-operative lateral plain film radiograph of the patient’s left
hip. No cause of the patient’s mechanical symptoms was detected
Fig. 1 Post-operative anterior–posterior plain film radiograph of the
patient’s left hip. No cause of the patient’s mechanical symptoms was
detected
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Discussion
Detection of MoM CSM is very challenging using plain ra-
diographs [2]. However, we have developed a method that
uses CT to identify CSM in MoM patients. Our imaging tech-
nique includes: 3D CT with metal artefact reduction, a low
radiation dose protocol and a softwaremeasurement technique
[8]. The main limitation of the technique is the requirement to
know component specifics regarding dimensions (e.g. if there
is a designed offset bore [9]). This poses a problem if the types
of component implanted/design specifics of the component
are unknown. Another limitation of the technique is that it is
time-consuming and requires proficiency in 3D CT analysis
software. This may limit its use in clinical practice.
The same principle can be applied to 2D CT slices (Fig. 3),
by comparing the distance between the outer surface of the
acetabulum and the femoral head (AC–FH). Owing to metal
artefact this was only possible at the edge of the acetabulum.
For this reason, patients with mismatches due to oversized
heads may go undetected because at the acetabular edge over-
sized femoral heads are centrally located and the AC–FH dis-
tance is equal (Fig. 7). We therefore recommend that 3D
models are still generated to accurately visualise the difference
between the femoral and acetabular centre of rotations in all
planes.
Themethodwas used to detect a mislabelled oversized cup,
as the centre of rotation of the acetabular and femoral head
components did not overlap, plus the femoral head did not sit
centrally in the acetabular component (Figs. 4, 5). If the fem-
oral component was oversized, the centres of rotation of the
acetabulum and femoral head components would not overlap,
but the femoral head would remain centrally positioned in the
acetabulum (Fig. 7).
Metal ions are known to increase in patients who have
MoM implants and there is increasing concern over their tox-
icity [10]. Furthermore, there is no clear consensus on what
counts as normal chromium and cobalt ion levels. The best
published evidence has suggested that the normal upper limit
of blood metal ions in patients with MoM implants is between
0.5 and 2.5 ppb for chromium and 0.7 and 3.4 ppb for cobalt
[11]. Another study indicated serum chromium ion levels
above 17 ppb and serum cobalt levels above 19 ppb are likely
to result in metallosis [12]. In this case, the patient had metal
ions far higher than the normal limit in MoM patients. In
addition, the patient would likely have developed metallosis
had the detection of CSM and prompt revision not occurred
[12].
Currently, proper procedure dictates that only the labels on
the boxes are checked and noted. This is because, while the
engravings on the acetabulum (Fig. 6) can be seen at revision,
Fig. 3 A 2D CTcoronal slice of the patient with the mismatched left hip
resurfacing (right) and the patient’s previous right hip resurfacing (left) in
view. The femoral head of the mismatched component is not sitting
centrally in the acetabular component with B being 1.5 times greater
than A. On the previous right hip resurfacing, with correctly paired
components, the femoral head is centrally placed (C to D)
Fig. 4 Three-dimensional model of the patient’s metal-on-metal (MoM)
resurfacing. The acetabular (A) and femoral head (B) centres of rotation
have been marked and the red arrow demonstrates that the two points are
not overlapping, which indicated component size mismatch (CSM)
Table 1 Parameters of the low-dose CT protocol
Area scanned kV mAs Scan length (cm)a Collimation
ASIS–stem tip 100 100 30 128*0.625
Knee 100 70 20 128*0.625
Ankle 100 45 10 24*1.25
ASIS anterior superior iliac spine
a Scan length varies depending upon patient size and component. An
anterior–posterior topogram should be acquired to determine scan range.
All areas should be scanned using a pitch of 1.0 and rotation time of 1.0 s
and reconstructed using 1-mm slices and the kernel BBONE^. An extend-
ed scale should be used.
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they are not visible before implantation as they are packaged
with an impactor cap attached (Fig. 8).
Mislabelling of components has previously been reported
on two occasions. In both instances the manufacturer recalled
the device, a statement was made by the US Food and Drug
Administration and a Medical Device Alert was given by the
Medicines and Healthcare Regulatory Agency [13, 14].
Advice from the Medicines and Healthcare Regulatory
Agency suggested that the plain radiographs of anyone
suspected of being fitted with an incorrect prosthesis should
be obtained [14]. However, previous work has demonstrated
that CSM may be missed using plain radiographs [2].
Cases of mismatch due to surgical error (mismatching of
correctly packaged components) have also previously been
reported. However, these cases do not require imaging for
detection, provided that the notes are available to be checked.
To reduce the incidence of CSM, we recommend that com-
ponent sizes are documented on the whiteboard in theatre (in
the same way the swab count check is performed). In addition,
this case highlights the importance of attempting to check the
engravings on the acetabular component after insertion and
not just relying on the boxes/stickers. However, this is not
always achievable as the implant lies deep in the wound, the
engravings are often obscured by blood or overhanging ace-
tabular bone and the engravings may not be on the same side
as the surgeon. Furthermore, even if the surgeon saw
B56 mm^, there are two different acetabular components with
an external diameter of 56 mm. The external diameter of
56 mm is also one of two acceptable pairings that can be used
with a 48-mm head. Consequently, both numbers need to be
visualised.
Future work will incorporate the lessons learned from this
case and retrieval data on mismatches to develop a modified
WHO checklist with the aim of reducing the incidence of
CSM.Within the modified WHO checklist it would be imper-
ative for the engravings on the components to be directly
visualised, either post-implantation or, if this proves too diffi-
cult to implement, pre-implantation, following a redesign of
the impactor caps.
We applied our method to a patient referred with suspected
CSM. Based on our results we recommended revision surgery,
and analysis of explanted components confirmed the CSM. To
our knowledge, this case is the first report of a CT method
being used in a patient to pre-operatively identify CSM. We
believe that this CT method will be useful in identifying CSM
of MoM components in patients whose surgical notes are
unobtainable.
Fig. 5 Lateral (left) and true anterior–posterior of the acetabular cup
(right) views of a three-dimensional model of the patient’s MoM
resurfacing. A is the acetabular centre of rotation and B is the femoral
head centre of rotation. The red arrows indicate that the femoral head is
not centred in the acetabulum, which suggests CSM
Fig. 6 Photo of the revised Adept hip resurfacing removed from the 53-
year-old gentleman. Manufacturer labels in the surgical notes record the
components as being a 56-mm cup designed for a 48-mm head and a 48-
mm head. Engravings (red arrows) and coordinate measuring machine
measurements confirm the CSM, as the cup is actually a 56-mm cup
designed for a 50-mm head
Fig. 7 Two 3Dmodels of potential CSMs: oversized femoral head (left);
oversized acetabulum (right). The white outline reveals that the femoral
head sits centrally in the acetabulum in cases where the femoral head is
oversized. In CSM cases where the acetabulum is oversized (as
presented) the femoral head does not sit centrally
Fig. 8 Photo of an acetabular component with the impactor cap still
attached. The impactor cap covers the engravings and is removed only
after insertion
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